跳至主要内容
临床试验/CTRI/2020/07/026503
CTRI/2020/07/026503已完成2 期

Nidanatmaka study of Dadru Kushtha and Upashayatmaka Randomised trial toevaluate the efficacy of Mulakadi Lepa and Guduchyadi kwatha in themanagement of Dadru Kushtha.

National Institute of Ayurveda1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2020年10月7日最近更新:

试验速览

阶段
2 期
状态
已完成
入组人数
100
试验地点
1
主要终点
Improvement in skin lesions (mandala).

研究概览

简要总结

Dadru involves the clinical features like Kandu, Deerghapratana, Utsanna,

Mandala, Raaga, Pidakas, which exhibits involvementof Kapha and Pitta. Acharya

Vagbhata especially mentioned Dadru as Anusangika.Ayurvedic classics have

considered each type of Kushtha to be a Tridoshaja manifestation. Nonetheless,

their Doshik identity can established based on dominance of Dosha in the

Samprapti. Thus, Dadru is purely Kaphaja phenomenon. Based on presenting

symptomatology most of the scholars have similated Dadru with ’Fungal

dermatocytes through modern perspective. It comes under, superficial fungal

infections of the skin.

Globally, up to 20% of the population may be infected by ringworm at any given

time

AIMS AND OBJECTIVE:

To conduct a Nidanatmaka (survey) study to know the etiopathogenesis of ‘Dadru’

Kushtha.

To evaluate and compare the efficacy of Guduchyadi Kwatha & Mulakadi Lepa in

the management of ‘Dadru’ Kushtha.

HYPOTHESIS:

NULL HYPOTHESIS (H0): Trial drugs Mulakadi Lepa and Guduchyadi kwatha

are no difference in the management of ‘Dadru’ Kushtha

ALTERNATIVE HYPOTHESIS (H1): Trial drugs Mulakadi Lepa and Guduchyadi

kwatha are difference in the management of ‘Dadru’ Kushtha

研究设计

研究类型
Interventional
分配方式
Computer generated randomization
盲法
Open Label

入排标准

年龄范围
18.00 Year(s) 至 60.00 Year(s)(—)
性别
All

入选标准

  • Patient with the classical sign and symptoms of Dadru Kushtha viz.
  • kandu, raga, pidika and mandala.
  • Patients 18 years to 60 years of age will be included.
  • Patients belonging to either gender will be included.

排除标准

  • The patient suffering from severity systemic disorders will be excluded.
  • The pregnant women and lactating mother will be excluded.
  • Patient less than 18 yrs and above 60 yrs of age will be excluded.
  • Skin malignancy and other skin diseases.

结局指标

主要结局

Improvement in skin lesions (mandala).

时间窗: 30 days

次要结局

  • Improvement in the following signs and symptoms- kandu,raga, pidika(30 days)

研究者

申办方类型
Research institution and hospital

研究点 (1)

Loading locations...

相似试验